Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04587960
Other study ID # ECR/771/Inst/WB/2015/RR-18
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2021
Est. completion date June 15, 2021

Study information

Verified date September 2021
Source Calcutta National Medical College and Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pregnant mothers requiring emergency cs with history of ruptured membranes would be allocated randomly into two groups in an aim to study the comparative outcome of different methods of skin closure namely primary and delayed primary closure on the incidence of wound infections requiring secondary closures and to detect the associated risk factors increasing chance of surgical site infections.


Description:

OBJECTIVE • To compare the effect of two different methods of skin wound closure namely Primary Closure and Delayed Primary Closure on the incidence of wound infection and requirement for secondary skin wound repair after emergency caesarean section in patients with ruptured membranes. RESEARCH HYPOTHESIS Caesarean Sections (CS) in emergency situation where amniotic membrane is ruptured are clean contaminated procedures which are associated with 10-20% wound disruptions. Delayed Primary Closure for managing contaminated wounds is a concept well recognized by military surgeons, which reduces wound infections. Investigators wish to conduct this prospective study to determine the efficacy of using this technique of wound closure in Caesarean Sections in patients with history of ruptured amniotic membranes. Investigators wish to study and compare the effect of this technique versus conventional primary skin closure on wound infection and incidence of secondary wound suturing in CS with ruptured membranes. MATERIALS AND METHODS: 1. STUDY DESIGN: Randomized controlled Trial 2. STUDY SETTING: Tertiary teaching hospital-based trial involving obstetric patients undergoing Caesarean delivery. 3. PLACE OF STUDY: Department of Obstetrics and Gynecology, Calcutta National Medical College and Hospital, Kolkata. 4. PERIOD OF STUDY: From 1st March 2020 to 15th June 2021. 5. SAMPLE SIZE: As no similar study was found in literature related to obstetric population, we have chosen an arbitrary sample size of 30 in case group and 30 in control group in this Pilot study. 6. STUDY POPULATION: INCLUSION CRITERIA : • Parturients admitted with rupture of membranes undergoing emergency CS EXCLUSION CRITERIA : - Presence of intact membranes - Incision other than Pfannenstiel - Presence of pre-existing infection at the site of skin incision - Presence of obvious chorioamnionitis - Presence of any immunosuppressive condition including HIV, intake of immunosuppressive medication, h/o chemotherapy, haematological malignancies, etc. - Presence of other conditions interfering with wound healing like Tuberculosis, Diabetes, collagen disorders, etc. i) PROCEDURE: Mothers undergoing emergency CS for various indications after rupture of membranes will be randomly allocated to two groups Study group to undergo Delayed Primary Closure of skin incision and Control group to undergo Primary closure of skin incision, after appropriate consenting. During CS Pfannenstiel incision will be made in the skin. All patients will receive prophylactic antibiotic within thirty minutes of making abdominal incision. Depending upon the duration of membrane rupture wound will be defined either contaminated (duration of membrane rupture ≥ 12 hours) or clean contaminated (duration of membrane rupture ≤12 hours). At the end of the procedure after closure of rectus sheath in the Study group, interrupted stitches will be taken through skin and subcutaneous tissue with 1-0 monofilament suture but knots will not be tightened and skin will be left open. Following operation, from next day onwards dressing of the wound will be done for 3 days. On 4th day, the monofilament stitches will be tightened under local anaesthesia to appose the skin. Thereafter, sutures will be removed on 7th day after operation. In the Control group wound margins will be apposed by primary closure by interrupted stitches using 1-0 monofilament and stitches will be removed on 6th day after operation. If there is abnormal discharge from wound, wound swabs will be taken for bacterial culture sensitivity test. If there is wound dehiscence, timing of secondary closure will be decided based on wound health and presence of adequate granulation tissue after a period of regular wound dressing. STASTICAL ANALYSIS PLAN Statistical methods- Linear data will be represented a mean ± standard deviation for normally distributed data and as mean (interquartile range (IQR)) for not-normally distributed data. Categorical data will represented as percentage (frequency). Comparison of means will be done with Mann Whitney U test and comparison of proportions with Chi - squared test or Fisher's exact test as appropriate. Multivariate modeling with logistic regression will be used to compare different variables between the primary closure and delayed primary closure groups.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date June 15, 2021
Est. primary completion date June 15, 2021
Accepts healthy volunteers No
Gender Female
Age group 21 Years to 40 Years
Eligibility INCLUSION CRITERIA : • Parturients admitted with rupture of membranes undergoing emergency CS EXCLUSION CRITERIA : - Presence of intact membranes - Incision other than Pfannenstiel - Presence of pre-existing infection at the site of skin incision - Presence of obvious chorioamnionitis - Presence of any immunosuppressive condition including HIV, intake of immunosuppressive medication, h/o chemotherapy, haematological malignancies, etc. - Presence of other conditions interfering with wound healing like Tuberculosis, Diabetes, collagen disorders, etc.

Study Design


Intervention

Procedure:
Delayed primary closure of skin incision in Caesarean section in experimental group
Delayed closure of skin wound of emergency Caesarean section following wound dressing for 2-3 days in experimental group
Primary closure of skin incision in Caesarean section in active comparator group
Primary closure of skin wound (incisional) at the time of emergency Caesarean section in active comparator group

Locations

Country Name City State
India Calcutta National Medical College and Hospital Kolkata West Bengal

Sponsors (1)

Lead Sponsor Collaborator
Dr.Jhuma Biswas

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Surgical site infections requiring secondary closure Incidence of surgical site infections requiring secondary closure 6 days from the day of surgery
Secondary Prolonged hospital stay Requiring prolonged hospital stay due to wound infection more than 7 days after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT03960970 - Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries Phase 2
Recruiting NCT05920122 - Aqueous vs Alcohol Chlorhexidine Skin Preparation for Prevention of Cesarean Section Wound Infections Phase 4
Active, not recruiting NCT04359472 - The Collection and Application of Autologous Amniotic Fluid at Cesarean Delivery Closure. N/A
Completed NCT03640507 - Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline Phase 2/Phase 3
Completed NCT05330650 - Evaluation of Triclosan Coated Suture in Obstetrical Surgery Phase 4
Completed NCT04365452 - The Invia Motion at Cesarean Study Phase 4
Completed NCT03838965 - The Effects of Labor Stages and Interventions on Hemodynamic Measures During & After Childbirth With Noninvasive Sensors N/A
Not yet recruiting NCT06339203 - Intraoperative Wound Irrigation in Cesarean Section N/A
Completed NCT05807633 - Performance of Novosyn® in Patients Undergoing Uterus Closure in Cesarean Section
Not yet recruiting NCT03672214 - Caesarean Delivery With or Without an Indwelling Bladder Catheter N/A
Recruiting NCT03500055 - Abdominal Closure Bundle to Reduce Surgical Site Infection in Patients Undergoing C-sections. Cesarean Section Lead to Reduction in Surgical Site Infection? - A Randomized Controlled Trial N/A
Recruiting NCT03386240 - Antibacterial-coated Sutures at Time of Cesarean Phase 4
Completed NCT03284749 - Effect of Copper on the Healing of Obstetric Wounds N/A
Active, not recruiting NCT06048692 - Cefepime and Unictam on Preventing Post-Cesarean Surgical Site Infections Phase 3
Completed NCT06119113 - Wound Infection Due to Suture Material in Caesarean Skin Incision and Evaluation of Cosmetic Results N/A
Terminated NCT03479931 - Caesarean Delivery With or Without an Indwelling Bladder Catheter. A Randomised Trial. N/A
Recruiting NCT04476212 - Prophylaxis of Surgical Wound Infection With Topical Antibiotics N/A
Completed NCT03536832 - Subcuticular Skin Closure at Cesarean Delivery N/A